138 related articles for article (PubMed ID: 37725592)
1. A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience.
Gupta MK; Misariu AM; Saydy N; Nichols AC; Laxague F; Eskander A; Li H; Weisbrod N; Pasternak JD; Golbon B; Jin E; van Uum SHM; Brassard M; Lévesque F; Sadeghi N; Subramaniam T; Mlynarek AM; Morand GB; Fortier PH; Fradet L; Ghaznavi S; Chandarana SP; Prisman E; Ayad T; Christopoulos A; Davies JC; Rajaraman M; Corsten M; Rajaraman K; Maniakas A
Thyroid; 2023 Nov; 33(11):1374-1377. PubMed ID: 37725592
[No Abstract] [Full Text] [Related]
2. Anaplastic thyroid carcinoma: review of treatment protocols.
Tiedje V; Stuschke M; Weber F; Dralle H; Moss L; Führer D
Endocr Relat Cancer; 2018 Mar; 25(3):R153-R161. PubMed ID: 29295821
[TBL] [Abstract][Full Text] [Related]
3. Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer.
Li W; Li Y; Li J; Pang H
Technol Cancer Res Treat; 2023; 22():15330338231169870. PubMed ID: 37122242
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Management of Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I; Lam AK
Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic Thyroid Cancer: New Horizons and Challenges.
Maniakas A; Zafereo M; Cabanillas ME
Endocrinol Metab Clin North Am; 2022 Jun; 51(2):391-401. PubMed ID: 35662448
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatment of anaplastic thyroid cancer with nearly resolved effect.
Tseng YT; Chang TC
J Formos Med Assoc; 2015 Sep; 114(9):897-8. PubMed ID: 24755268
[No Abstract] [Full Text] [Related]
8. Anaplastic thyroid cancer.
Ranganath R; Shah MA; Shah AR
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):387-91. PubMed ID: 26313900
[TBL] [Abstract][Full Text] [Related]
9. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
10. Management of the compromised airway and role of tracheotomy in anaplastic thyroid carcinoma.
Mani N; McNamara K; Lowe N; Loughran S; Yap BK
Head Neck; 2016 Jan; 38(1):85-8. PubMed ID: 25215461
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.
Abe I; Lam AK
Histol Histopathol; 2021 Mar; 36(3):239-248. PubMed ID: 33170501
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience.
Al-Jumayli M; Kawsar HI; Neupane P
Am J Ther; 2022 Nov-Dec 01; 29(6):e714-e716. PubMed ID: 32889810
[No Abstract] [Full Text] [Related]
13. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model.
Marano F; Frairia R; Rinella L; Argenziano M; Bussolati B; Grange C; Mastrocola R; Castellano I; Berta L; Cavalli R; Catalano MG
Endocr Relat Cancer; 2017 Jun; 24(6):275-286. PubMed ID: 28487350
[TBL] [Abstract][Full Text] [Related]
14. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
15. ASO Author Reflections: Applying the Lens of Equity to Anaplastic Thyroid Cancer Care.
Ginzberg SP; Gasior JA; Wachtel H
Ann Surg Oncol; 2023 Oct; 30(11):6799-6800. PubMed ID: 37523118
[No Abstract] [Full Text] [Related]
16. Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.
Lennon P; Deady S; Healy ML; Toner M; Kinsella J; Timon CI; O'Neill JP
Head Neck; 2016 Apr; 38 Suppl 1():E1122-9. PubMed ID: 26879282
[TBL] [Abstract][Full Text] [Related]
17. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Jiménez-Fonseca P; Gómez Saez JM; Santamaria Sandi J; Capdevila J; Navarro Gonzalez E; Zafon Llopis C; Ramón Y Cajal Asensio T; Riesco-Eizaguirre G; Grande E; Galofré JC
Clin Transl Oncol; 2017 Jan; 19(1):12-20. PubMed ID: 27048161
[TBL] [Abstract][Full Text] [Related]
18. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
[TBL] [Abstract][Full Text] [Related]
19. Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer.
Zhao B; Aggarwal A; Marshall JA; Barletta JA; Kijewski MF; Lorch JH; Nehs MA
Surgery; 2022 Jan; 171(1):227-234. PubMed ID: 34334212
[TBL] [Abstract][Full Text] [Related]
20. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
